Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Net Income: 2021-2025

Historic Net Income for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to -$12.9 million.

  • ProQR Therapeutics N.V's Net Income fell 44.50% to -$12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.2 million, marking a year-over-year decrease of 79.87%. This contributed to the annual value of -$29.7 million for FY2024, which is 1.11% up from last year.
  • As of Q3 2025, ProQR Therapeutics N.V's Net Income stood at -$12.9 million, which was up 6.53% from -$13.8 million recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Net Income registered a high of -$3.1 million during Q2 2024, and its lowest value of -$23.4 million during Q3 2022.
  • Over the past 3 years, ProQR Therapeutics N.V's median Net Income value was -$8.9 million (recorded in 2024), while the average stood at -$8.9 million.
  • In the last 5 years, ProQR Therapeutics N.V's Net Income spiked by 74.62% in 2023 and then slumped by 342.01% in 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Net Income (Quarterly) stood at -$20.8 million in 2021, then soared by 34.89% to -$13.6 million in 2022, then spiked by 56.56% to -$5.9 million in 2023, then plummeted by 68.70% to -$9.9 million in 2024, then slumped by 44.50% to -$12.9 million in 2025.
  • Its last three reported values are -$12.9 million in Q3 2025, -$13.8 million for Q2 2025, and -$10.6 million during Q1 2025.